Skip to content
Use caution Medical device recall · FDA · Published October 5, 2026

Luminex Recalls LIAISON PLEX Assay Due to Diagnosis Risk

Luminex recalls LIAISON PLEX Gram-Negative Blood Culture Assay (Cat. No. 20-005-303) because updated instructions may lead to incorrect or delayed diagnosis of bloodstream infections.

🇺🇸 FDA recall #Z-0359-2027Medical deviceLuminex ›
✎ GovInfoNow plain-language explainer

Luminex Corporation is recalling the LIAISON PLEX Gram-Negative Blood Culture Assay, specifically Catalog No. 20-005-303 across all lots. The recall addresses an issue where the Instructions for Use were updated to recommend repeat testing for positive family-level results, a change intended to prevent incorrect or delayed diagnoses of bloodstream infections. Approximately 30,168 test cartridges (2,514 kits) are affected by this nationwide distribution. Read more at govinfonow.com/recall/2255608-luminex-corporation-recalls-liaison-plex-gram-negative-blood-culture-assay.

Source Summary by GovInfoNow · govinfonow.com/recall/2255608-luminex-corporation-recalls-liaison-plex-gram-negative-blood-culture-assay · Published November 17, 2026 · Updated November 17, 2026 · FDA enforcement record: FDA #Z-0359-2027

Cite this page

“Luminex Recalls LIAISON PLEX Assay Due to Diagnosis Risk.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2255608-luminex-corporation-recalls-liaison-plex-gram-negative-blood-culture-assay. Based on FDA recall #Z-0359-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0359-2027%22&limit=1).

The FDA announced on October 5, 2026, that Luminex Corporation is recalling the LIAISON PLEX Gram-Negative Blood Culture Assay because updated instructions may lead to incorrect or delayed diagnosis of bloodstream infections. The recall affects all lots of catalog number 20-005-303.

How to tell if you have it

  • Brand: Luminex
  • Product: LIAISON PLEX Gram-Negative Blood Culture Assay
  • Catalog No.: 20-005-303
  • Lots: All lots

The hazard

The hazard involves instructions for use that were updated to include explicit guidance recommending repeat testing whenever a positive family-level only result is obtained. This issue may contribute to incorrect or delayed diagnosis of bloodstream infection.

Context

GovInfoNow's records show Luminex Corporation has 23 other recalls on record since May 8, 2018. Other recent recalls include the Luminex VERIGENE Gram Negative Blood Culture Test Recall (April 16, 2025), the Luminex Verigene Gram Positive Blood Culture Test Recall (June 20, 2024), and the Luminex VERIGENE BC-GP Utility Tray Recall (November 7, 2023). Other recent recalls of similar products include the Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (July 13, 2026), the Meridian Bioscience Revogene C. difficile Test Recall (December 5, 2025), and the Beckman Coulter Emit 2000 Quinidine Assay Recall (July 13, 2026).

How to tell if you have this one

Check if you have the LIAISON PLEX Gram-Negative Blood Culture Assay with Catalog No. 20-005-303. The recall applies to all lots of this specific catalog number, and the UDI-DI is listed as pending. These products were distributed nationwide within the US.

  • Brand
    Luminex
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Review Updated Instructions

    Consult the updated Instructions for Use to ensure you follow the explicit guidance on repeat testing when a positive family-level only result is obtained.

  2. Contact Luminex Corporation

    Reach out to Luminex Corporation directly for further information or specific instructions regarding this recall, as no other remedy details are provided in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US distribution nationwide. No OUS distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Oct 5, 202612. FDA classified it Class II: Nov 5, 202623. Published in FDA’s Enforcement Report: Nov 11, 202634. Added to GovInfoNow: Nov 17, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0359-2027 (October 5, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0359-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA